Caribou Biosciences Inc
CRBU
Get informed when a big investor buys or sells
+ FollowMarket Cap$144.8M
Close$
$-1.97
231.6% downside
Current Fair Value
231.6% downsideOvervalued by 231.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $144.80 Million |
|---|---|
| Enterprise Value | $160.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | 2.37 |
| Outstanding Shares | 95,861,716 |
Return
| Return on Equity | -130.58% |
|---|---|
| Return on Assets | -89.41% |
| Return on Invested Capital | -91.02% |
Valuation & Multiples
| P/E Ratio | -1.03 |
|---|---|
| PEG | 2.76 |
| Price to Sales | - |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 24.32 |
| Enterprise Value to EBIT | -1.37 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.21 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3827▼ 102.33% |
|---|---|
| Total Calls | 315,100▲ 294.86% |
| Total Puts | 120,600▲ 7.49% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 40.52%▲ 0.76% |
|---|---|
| Total Invested | $71.34M▲ 19.77% |
| Investors Holding | 142▲ 13.00% |
ESG Score
No data
About Caribou Biosciences Inc
2,021 employees